Authors Tietz F, Adams I, Lücke E, Schreiber J Patient Preference and Adherence Volume 17 DOI https://doi.org/10.2147/PPA.S381486 Background: Inhalation therapy is the cornerstone of treatment of bronchial asthma. A patient-specific selection of inhalation devices is necessary,…
Sebastiano Gangemi, MD, PhD Alessandro Tonacci, PhD Giulia Costanzo, MD Davide Firinu, MD 1Stefano Del Giacco, MD, PhD WAO Journal Published:April 08, 2023 DOI:https://doi.org/10.1016/j.waojou.2023.100764 Abstract Asthma is a chronic respiratory disease…
Ariangela J Kozik, Fernando Holguin, Leopoldo N Segal, Talal A Chatila, Anne E Dixon, James E Gern, Catherine Lozupone, Nicholas Lukacs, Carey Lumeng, Philip L Molyneaux, Nichole Reisdorph, Ivan Vujkovic-Cvijin, Alkis Togias, Yvonne J Huang DOI: 10.1165/rcmb.2022-0216ST Free PMC article Abstract This report presents…
Yenealem Solomon, Birhanemaskal Malkamu, Ayenew Berhan, Tahir Eyayu, Andargachew Almaw, Biruk Legese & Berhanu Woldu BMC Pulmonary Medicine volume 23, Article number: 96 (2023) Abstract Background Asthma is a diverse disease with various etiologic bases. Severe asthma can be associated with…
Saglani S, Yates L, Lloyd CM. Eur J Immunol. 2023 Mar 17:e2249919. doi: 10.1002/eji.202249919. Free Access Abstract Asthma is classically considered to be a disease of type 2 immune dysfunction,…
Research – Open Access Mohammad Talaei, Pauline M. Emmett, Raquel Granell, Hossein Tabatabaeian, Kate Northstone, Anna Bergström & Seif O. Shaheen Respiratory Research volume 24, Article number: 82 (2023) Abstract Background Longitudinal epidemiological data are scarce examining the relationship between dietary patterns…
ABSTRACT Background Severe uncontrolled asthma (SUA) is frequently treated with biologic therapy if a T2 phenotype is found. Bronchoscopy is not routinely recommended in these patients unless a specific indication…
P. Jane McDowell PhD MBBS, J. Busby PHD & Liam G. Heaney MD Abstract Purpose Advances in the management of severe, eosinophilic asthma have improved, but asthma exacerbations continue to occur. This review…
A fifth of patients no longer needed oral steroids 2 years after starting biologic by Salynn Boyles SAN ANTONIO — Treatment with the interleukin-5 (IL-5) antagonist mepolizumab (Nucala) increased freedom from…
Ron Goldberg Patients with asthma and obesity had longer hospitalizations, higher care costs, and a more near-fatal asthma events than those without obesity. An increased risk for near-fatal asthma events…